EU Probes Ferrari McLaren Tobacco Deals

The intricate world of Formula 1, a sport synonymous with speed, innovation, and global marketing, finds itself once again at the crossroads of corporate sponsorship and public health regulations. In a significant development, the European Union’s Health, Food Safety and Energy Union department has confirmed it is “closely examining” recent initiatives by major tobacco companies involving prominent Formula 1 teams. This scrutiny underscores the ongoing tension between the sport’s commercial ambitions and the widespread ban on tobacco advertising.

The EU’s intervention follows a series of high-profile announcements that have brought the tobacco debate back into the spotlight of motorsport. Notably, Ferrari’s official entry for the 2019 season was amended to ‘Scuderia Ferrari Mission Winnow’, a clear reference to Philip Morris International’s (PMI) corporate initiative. Mission Winnow positions itself as a drive towards a smoke-free future, advocating for alternatives to traditional cigarettes. Similarly, McLaren announced a partnership with British American Tobacco (BAT), promoting its “A Better Tomorrow” initiative, described as part of BAT’s broader “Transforming Tobacco” campaign aimed at reducing the health impact of its products.

These initiatives, while framed around corporate transformation and harm reduction, have immediately raised red flags among health authorities and regulatory bodies. The central question revolves around whether these campaigns constitute a subtle, yet effective, form of tobacco promotion, thereby circumventing long-standing bans designed to protect public health. The implications for Formula 1, its teams, and its global audience are profound, potentially forcing a reassessment of what constitutes acceptable sponsorship in a world increasingly hostile to the tobacco industry.

Sponsored content. Support independent journalism by becoming a RaceFans Supporter.

A Brief History of Tobacco and Formula 1: From Dominance to Disappearance

The relationship between Formula 1 and the tobacco industry is long and storied, stretching back to an era when tobacco money flowed freely into the sport. For decades, iconic brands like Marlboro, Rothmans, Camel, West, and Mild Seven adorned the liveries of championship-winning cars and the racing suits of legendary drivers. This era cemented a powerful visual association between the glamour, speed, and success of Formula 1 and the tobacco industry, making it a highly effective global marketing platform. Tobacco sponsorships provided crucial financial backing, enabling teams to push technological boundaries and expand the sport’s reach.

However, as public awareness of the devastating health consequences of smoking grew, so did the pressure from health organizations and governments to curb tobacco advertising. The tide began to turn in the late 1990s and early 2000s, leading to a phased withdrawal of tobacco sponsorship across many sports, particularly in Europe. The European Union spearheaded much of this regulatory change, culminating in a comprehensive ban that fundamentally reshaped the commercial landscape of Formula 1. The memory of those vibrant, tobacco-branded cars remains a powerful symbol of a bygone era, starkly contrasting with today’s stringent regulations.

The EU’s Firm Stance: Unpacking the Tobacco Advertising Directive

At the heart of the current controversy lies the European Union’s robust regulatory framework against tobacco promotion. A pivotal moment was the adoption of the 2003 EU Tobacco Advertising Directive (2003/33/EC), which implemented a sweeping ban on all forms of tobacco advertising and sponsorship across EU member states. This directive covered print media, radio, internet, and international events, explicitly targeting sports sponsorships like those in Formula 1. The directive’s intent was unequivocal: to protect public health by preventing the promotion of tobacco products, thereby reducing their appeal and consumption.

Recognizing the evolving nature of the tobacco market, the EU further updated its regulations with the 2014 Tobacco Products Directive (2014/40/EU). This update expanded the scope to include emerging forms of tobacco consumption, such as electronic cigarettes and heated tobacco products. The continuous monitoring and enforcement of these directives fall under the purview of the EU’s Health, Food Safety and Energy Union department, which now finds itself tasked with interpreting these laws in the context of the new “corporate initiative” sponsorships. As Anca Padurara, a spokesperson for the department, articulated, the Commission “continues to closely follow the implementation of the bans… also in the context of Formula 1,” and these recent initiatives “will require further close examination following which the Commission will proceed as necessary.” This statement signals a serious intent to uphold the spirit, not just the letter, of the law.

Ferrari and Philip Morris International: The Mission Winnow Initiative

Ferrari’s association with Philip Morris International dates back decades, with Marlboro being one of the most recognizable sponsors in F1 history. Even after direct tobacco branding was banned, PMI maintained its ties with Ferrari, albeit with more subtle branding or “barcode” logos that subtly evoked the Marlboro chevron. The introduction of ‘Mission Winnow’ marks a new chapter in this enduring partnership.

Mission Winnow is presented by PMI as a global initiative focused on driving change and innovation towards a “smoke-free future.” The company emphasizes its commitment to developing scientifically substantiated smoke-free products that are “healthier alternatives” to traditional cigarettes. The branding, prominently displayed on the Ferrari cars and within the team’s official name, consists of a distinctive green-and-white logo and typography. PMI has consistently asserted that Mission Winnow is a corporate campaign, not a tobacco product advertisement, and is designed to promote innovation, not smoking. A PMI spokesperson reiterated, “Let me reiterate that Mission Winnow is not, and will not, be used by [PMI] for any tobacco or nicotine containing products.”

Despite these assurances, the initiative has drawn significant criticism. Health authorities, including those in Australia, where Ferrari faced scrutiny during the Grand Prix, view Mission Winnow as a potential form of “stealth marketing” or “brand stretching.” Critics argue that by maintaining a visual presence and a deep association with a powerful global brand like Ferrari, PMI can keep its corporate identity, and by extension, its products, in the public consciousness. They contend that the campaign implicitly normalizes the tobacco industry and its products, even if it promotes “alternatives.” This controversy highlights the intricate challenge of distinguishing between legitimate corporate responsibility campaigns and thinly veiled marketing ploys in a highly regulated environment.

McLaren and British American Tobacco: “A Better Tomorrow”

Not long after the Mission Winnow debate began to simmer, McLaren announced its own partnership with British American Tobacco (BAT), another global tobacco giant. This collaboration introduced the “A Better Tomorrow” slogan, part of BAT’s broader “Transforming Tobacco” campaign. Similar to PMI’s narrative, BAT positions “A Better Tomorrow” as a forward-looking initiative, signaling its commitment to offering adult smokers a “greater choice of enjoyable and less risky products.” These products include vaping devices, heated tobacco, and oral tobacco pouches, which BAT claims are central to its strategy for reducing the health impact of its business.

BAT’s press release explicitly stated that the “A Better Tomorrow” slogan would have “on-car and off-car presence,” with the branding expected to be revealed during the launch of the McLaren MCL34 car. The company, much like PMI, has been careful to state that its message will “at all times [be] in line with applicable regulation and legislation.” This partnership marks a return of a tobacco industry giant to McLaren, reminiscent of previous eras when brands like West sponsored the team. The recurrence of such partnerships, albeit under a new guise, underscores the enduring appeal of Formula 1 as a marketing platform for these companies, even as they attempt to reinvent their public image.

However, this initiative faces the same questions of compliance and ethics as Mission Winnow. Critics argue that despite the focus on “reduced-risk products,” the underlying association with a tobacco company remains problematic. Public health advocates worry that these campaigns could inadvertently normalize tobacco companies and their products, making them appear more palatable or “modern” to a younger demographic. The sheer global reach and visibility of Formula 1 mean that any branding, however indirect, can have a significant impact on public perception, particularly in regions with less stringent advertising regulations.

The FIA’s Mandate and the Road Ahead

Beyond the EU’s regulatory authority, Formula 1’s governing body, the FIA (Fédération Internationale de l’Automobile), also has its own rules regarding tobacco sponsorship. The FIA banned direct tobacco sponsorship in the sport from the end of 2006, imposing regulations largely based on prevailing EU laws and World Health Organisation (WHO) guidelines. This ban was a critical step in aligning F1 with global health initiatives and modern ethical standards for sports marketing.

The current situation presents a complex challenge for the FIA. While the new initiatives do not directly advertise traditional cigarettes, they leverage the corporate names of tobacco manufacturers. The FIA must now navigate the nuances of these “corporate responsibility” campaigns and determine whether they adhere to the spirit and letter of its own regulations. The distinction between a corporate initiative promoting a “better tomorrow” and a subtle form of brand promotion for a tobacco company is a fine line, one that regulatory bodies globally are grappling with. Should the EU or other health authorities deem these initiatives non-compliant, the FIA would be compelled to take action, potentially leading to demands for removal of branding, fines, or other penalties that could significantly impact the teams and the sport’s commercial agreements.

The broader implications extend beyond specific teams. Formula 1, under new ownership, has been striving to cultivate a modern, family-friendly image, attracting new sponsors and a younger audience. A renewed association, however indirect, with the tobacco industry risks undermining these efforts and could draw criticism from partners, broadcasters, and fans alike. The ongoing examination by the EU serves as a critical test case, not just for Ferrari and McLaren, but for the entire sport’s commitment to public health and its ability to maintain a clear stance against tobacco promotion in any form.

Conclusion: The Unfolding Chapter of Tobacco and F1

The “close examination” by the European Union of the Mission Winnow and “A Better Tomorrow” initiatives marks a crucial juncture in the ongoing narrative of tobacco and Formula 1. It represents a determined effort by regulatory bodies to ensure that the spirit of advertising bans is upheld, even as tobacco companies innovate their marketing strategies. The outcomes of these examinations will set important precedents, influencing not only future sponsorship deals in Formula 1 but also the broader landscape of corporate advertising by industries under public health scrutiny.

Formula 1 faces a delicate balancing act: maintaining its commercial viability while adhering to global ethical standards and regulatory demands. The debate highlights the enduring allure of motorsport for major corporations and the persistent challenge for public health advocates to counter sophisticated marketing tactics. As the EU concludes its review, the future of these partnerships, and potentially the face of Formula 1 branding, hangs in the balance, underscoring that the fight against tobacco promotion continues to evolve on the world stage.